Rapid Dose Therapeutics Commits to NFL-Funded Clinical Trial Application
(marketscreener.com) Rapid Dose Therapeutics Corp. announces its collaboration in the National Football League – funded clinical trial program entitled “Naturally Produced Cannabinoids for Pain Management and Neuroprotection from Concussion and Participation…
Burlington, Ontario–(Newsfile Corp. – May 29, 2024) – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Company”) announces its collaboration in the National Football League (NFL) funded cli…